Results 251 to 260 of about 1,888,313 (328)

Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus. [PDF]

Front Immunol
do Nascimento GM, de Oliveira PSB, Butt SL, Diel DG.   +3 more
europepmc   +1 more source

A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity. [PDF]

Hum Vaccin Immunother
Klinkardt U, Schunk M, Ervin J, Schindler C, Sugimoto D, Rankin B, Amann R, Monti M, Kutschenko A, Schumacher C, Huber K, Zeder A, Heikkila N, Didierlaurent AM, Schwarz SE, Derouazi M.   +15 more
europepmc   +1 more source

Image 2_The identification and genetic characteristics of the Orf virus strain (ORFV-CL24) isolated from Jilin province, China.tif

Lijun Lv (15274361), Fei Gao (29262), Jiyu Guan (8470497), Yiran Sun (4500298), Ran Zhang (117374), Zi Li (223785), Yungang Lan (6276290), Feng Gao (3548), Wenqi He (460919), Kui Zhao (826106)   +9 more
openalex   +1 more source

Genistein is effective in inhibiting Orf virus infection in vitro by targeting viral RNA polymerase subunit RPO30 protein. [PDF]

Front Microbiol
Lv P, Fang Z, Guan J, Lv L, Xu M, Liu X, Li Z, Lan Y, Li Z, Lu H, Song D, He W, Gao F, Wang D, Zhao K.   +14 more
europepmc   +1 more source

Detection and Phylogenetic Analysis of B2L Gene of ORF Virus from Clinical Cases of Sheep in Serbia

, 2019
Milovan Milovanović
openalex   +1 more source

An ORF-2a protein is not present at a significant level in virions of the arterivirus lactate dehydrogenase-elevating virus

, 2001
Peter G.W. Plagemann
openalex   +2 more sources

Novel Multi-Antigen Orf-Virus-Derived Vaccine Elicits Protective Anti-SARS-CoV-2 Response in Monovalent and Bivalent Formats. [PDF]

Vaccines (Basel)
Burri DJ, Renz L, Mueller M, Pagallies F, Klinkhardt U, Amann R, Derouazi M.   +6 more
europepmc   +1 more source

Detection and partial characterization of two new potexviruses infecting yams (Dioscorea spp.) [PDF]

, 2009
Filloux, Denis, Galzi, Serge
core  

Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2. [PDF]

Vaccines (Basel)
Metz C, Haug V, Müller M, Amann R.
europepmc   +1 more source

Orf virus infection in a herder: A zoonotic poxvirus mimicking Mpox and other cutaneous lesions [PDF]

Xu Li, Qiri Mu
openalex   +1 more source